Bruce G Haffty Selected Research

Therapeutics

10/2021	Proton Therapy for Breast Cancer: A Consensus Statement From the Particle Therapy Cooperative Group Breast Cancer Subcommittee.
1/2021	Cost-Effectiveness of Adjuvant Treatment for Ductal Carcinoma In Situ.
1/2019	SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with Snail and HDAC1/2.
1/2018	Borderline ER-Positive Primary Breast Cancer Gains No Significant Survival Benefit From Endocrine Therapy: A Systematic Review and Meta-Analysis.
10/2016	Oncoplastic breast surgery in the setting of breast-conserving therapy: A systematic review.
8/2016	Clinical characteristics and dose-volume histogram parameters associated with the development of pleural effusions in non-small cell lung cancer patients treated with chemoradiation therapy.
7/2015	Reduction in Tumor Volume by Cone Beam Computed Tomography Predicts Overall Survival in Non-Small Cell Lung Cancer Treated With Chemoradiation Therapy.
1/2015	The evolution of regional nodal irradiation in breast cancer.
11/2014	Radiation field design in the ACOSOG Z0011 (Alliance) Trial.
6/2014	Magnetic resonance-guided laser ablation improves local control for postradiosurgery recurrence and/or radiation necrosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bruce G Haffty Research Topics

Disease

129	Breast Neoplasms (Breast Cancer) 06/2022 - 01/2002
76	Neoplasms (Cancer) 01/2021 - 12/2002
21	Neoplasm Metastasis (Metastasis) 01/2021 - 03/2002
16	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2021 - 12/2002
9	Squamous Cell Carcinoma of Head and Neck 01/2019 - 01/2003
6	Laryngeal Neoplasms (Laryngeal Cancer) 06/2013 - 01/2004
4	Carcinoma (Carcinomatosis) 01/2018 - 09/2005
4	Necrosis 08/2017 - 12/2002
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2016 - 07/2006
3	Unilateral Breast Neoplasms 01/2021 - 01/2014
3	Glioma (Gliomas) 04/2019 - 05/2015
3	Cardiotoxicity 01/2019 - 01/2014
3	Triple Negative Breast Neoplasms 10/2017 - 06/2010
3	Lung Neoplasms (Lung Cancer) 09/2016 - 04/2013
3	Ductal Carcinoma 06/2015 - 12/2009
3	Colorectal Neoplasms (Colorectal Cancer) 06/2014 - 02/2010
3	Seroma 05/2014 - 11/2010
3	Squamous Cell Neoplasms (Squamous Cell Cancer) 04/2005 - 01/2005
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 09/2009
2	Pain (Aches) 01/2021 - 01/2020
2	COVID-19 01/2021 - 01/2021
2	Carcinogenesis 01/2020 - 04/2005
2	Cicatrix (Scar) 01/2020 - 06/2017
2	Parkinson Disease (Parkinson's Disease) 01/2020 - 11/2017
2	Fatigue 01/2020 - 09/2011
2	Infections 06/2017 - 09/2009
2	Heart Diseases (Heart Disease) 01/2015 - 09/2011
2	Brain Neoplasms (Brain Tumor) 06/2014 - 04/2011
2	Rectal Neoplasms (Rectal Cancer) 03/2014 - 01/2012
1	Severe Acute Respiratory Syndrome 07/2021
1	Lymphoma (Lymphomas) 01/2021
1	Leukemia 01/2021
1	Lymphedema (Milroy Disease) 01/2020
1	Glioblastoma (Glioblastoma Multiforme) 04/2019
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2019
1	Hypoxia (Hypoxemia) 11/2017

Drug/Important Bio-Agent (IBA)

21	Estrogen ReceptorsIBA 01/2018 - 05/2003
17	Proteins (Proteins, Gene)FDA Link 04/2019 - 04/2005
12	Progesterone Receptors (Progesterone Receptor)IBA 12/2019 - 05/2003
12	Hormones (Hormone)IBA 03/2017 - 10/2003
11	ParaffinIBA 02/2012 - 03/2003
7	Biological ProductsIBA 05/2016 - 03/2003
6	Estrogens (Estrogen)FDA Link 12/2019 - 07/2008
6	Biomarkers (Surrogate Marker)IBA 01/2014 - 05/2003
5	human ERBB2 proteinIBA 01/2019 - 06/2010
5	Dihydrotachysterol (AT 10)IBA 06/2010 - 07/2003
5	Cyclin D1IBA 07/2009 - 10/2003
4	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2014 - 01/2005
3	EnzymesIBA 01/2020 - 03/2010
3	Messenger RNA (mRNA)IBA 01/2019 - 06/2010
3	Indicators and Reagents (Reagents)IBA 06/2014 - 02/2010
3	GoldIBA 05/2014 - 11/2010
3	DNA (Deoxyribonucleic Acid)IBA 06/2010 - 02/2006
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2008 - 03/2004
3	Hemoglobins (Hemoglobin)IBA 01/2005 - 03/2004
2	Protons (Proton)IBA 10/2021 - 01/2021
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2020 - 11/2017
2	Riluzole FDA LinkGeneric 04/2019 - 04/2011
2	Glutamic Acid (Glutamate)FDA Link 04/2019 - 04/2011
2	Pharmaceutical PreparationsIBA 01/2019 - 05/2015
2	TIC10 compoundIBA 01/2019 - 08/2017
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2019 - 06/2014
2	Metformin (Glucophage)FDA LinkGeneric 03/2015 - 01/2013
2	Fulvestrant (Faslodex)FDA Link 08/2014 - 02/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 08/2014 - 01/2005
2	Tamoxifen FDA LinkGeneric 09/2013 - 01/2005
2	Carrier Proteins (Binding Protein)IBA 08/2012 - 06/2011
2	AntibodiesIBA 12/2011 - 02/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2011 - 02/2007
2	Cisplatin (Platino)FDA LinkGeneric 06/2010 - 03/2006
2	beta CateninIBA 09/2009 - 04/2005
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 03/2006 - 01/2005
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2003 - 01/2002
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Viral RNAIBA 01/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	Phosphoglycerate Dehydrogenase (Dehydrogenase, Phosphoglycerate)IBA 01/2020
1	Serine (L-Serine)FDA Link 01/2020
1	metabotropic glutamate receptor 3 (mGluR3)IBA 04/2019
1	Trastuzumab (Herceptin)FDA Link 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Co-Repressor ProteinsIBA 01/2019
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 05/2018

Therapy/Procedure

98	Radiotherapy 10/2021 - 03/2002
48	Segmental Mastectomy (Lumpectomy) 06/2022 - 04/2002
39	Therapeutics 10/2021 - 03/2002
26	Mastectomy (Mammectomy) 01/2021 - 03/2002
14	Drug Therapy (Chemotherapy) 01/2019 - 09/2005
9	Brachytherapy 01/2021 - 12/2008
6	Neoadjuvant Therapy 01/2019 - 10/2009
6	Adjuvant Radiotherapy 01/2013 - 10/2006
3	Lymph Node Excision (Lymph Node Dissection) 01/2019 - 10/2013
2	Salvage Therapy 06/2014 - 03/2004
2	Image-Guided Radiotherapy 04/2013 - 11/2007
2	Conservative Treatment 12/2006 - 04/2004
2	Duration of Therapy 11/2004 - 03/2004
1	Re-Irradiation 01/2022
1	Proton Therapy 10/2021
1	Treatment Delay 01/2021
1	Oral Administration 01/2019